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20298 | RSC Adv., 2013, 3, 20298–20Practical synthesis of trans-dihydroxybutyrolactols as
chiral C4 building blocks and their application to the
synthesis of polyhydroxylated alkaloids†
Jing Zeng, Qian Zhang, Hong-Kui Zhang* and Anqi Chen‡*
Practical syntheses of trans-dihydroxybutyrolactols 2a, 2b and 2c from inexpensive chiral pool compounds
L-ascorbic, D- and L-tartaric acid have been achieved on a multigram-scale. The synthetic applications of
these chiral building blocks have been demonstrated in the efficient total or formal synthesis of
polyhydroxylated alkaloids (+)-lentiginosine and ()-deacetylanisomycin in concise routes.Introduction
Structural motifs containing vicinal chiral polyhydroxy groups
are ubiquitous and commonly found in natural products with
therapeutic signicance, exemplied by polyhydroxylated alka-
loids. In the past few decades, more than 100 polyhydroxylated
alkaloids have been isolated, which can be categorised into
pyrrolidines, piperidines, pyrrolizidines, indolizines and nor-
tropanes based on their structural skeletons (Fig. 1). Poly-
hydroxylated alkaloids have also been classied as iminosugars
or azasugars due to their structural similarity to carbohydrates.
As a result, these iminosugars have been used as carbohydrateoccurring polyhydroxylated alkaloids.
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307mimics to inhibit various glycosidases in a reversible or
competitive manner, as well as tested for anticancer, anti-HIV
and immunoregulatory activities.1 The natural abundance of
polyhydroxylated alkaloids and their remarkable, diverse
bioactivities have stimulated much interest in the total
synthesis of these compounds.2 However, one of the major
challenges of their total syntheses lies in the efficient and
stereoselective construction of the contiguous polyhydroxy
groups. Despite the signicant advancement in the enantio-
and diastereoselective construction of polyhydroxy systems,
such as asymmetric dihydroxylation and epoxidation reactions,
the most common and powerful strategy remains to be the
‘chiron’ approach in which chiral building blocks (or synthons)
generated from readily available, optically pure natural mole-
cules are used as the starting materials.
Among the polyhydroxy chiral synthons, dihydroxybutyr-
olactols (Scheme 1, 1a–d) have long been recognized as valuable,
versatile building blocks and been widely utilized in the total
synthesis of natural products. The general strategy of the
synthetic application of dihydroxybutyrolactols includes nucle-
ophilic addition andWittig reactions on the lactolmoiety, which
is the equivalent of a masked aldehyde, to enable C–C bondScheme 1 Dihydroxybutyrolactols as building blocks.













































View Article Onlineformation and further chemical transformations and function-
alisations.3 However, the successful application of this strategy
has mainly been limited to cis-dihydroxybutyrolactols whereas
that of trans-dihydroxybutyrolactols is much less explored.4 In
conjunctionwith our continuing efforts in the explorationof new
synthetic applications of dihydroxybutyrolactols as building
blocks,5 we report herein practical and scalable syntheses
of trans-dihydroxybutyrolactols (1c and 1d) and their application
in the synthesis of polyhydroxylated alkaloids.Scheme 3 Synthesis of 2b and 2c from tartaric acid. (a) H2SO4 (cat. amount),
EtOH, reflux, 98%; (b) BnBr, Ag2O, rt, 48 h, 88%; (c) LiCl, KBH4, THF, reflux, 85%;
(d) IBX, DMSO, rt, 5 h, 87%.Results and discussion
Our study commenced with the development of practical
synthetic routes to trans-dihydroxybutyrolactols. We rst exam-
ined the synthesis of lactone 4, a precursor to lactol 1c, from
L-ascorbic acid (3) in a way similar to that for the preparation
of D-()-erythronolactone from D-ascorbic acid.6 Although D-()-
erythronolactone is commercially available and can be readily
prepared, the synthesis of its diastereomeric analogue 4 is
challenging due to its highly hygroscopic nature. Nevertheless,
by modifying Tenji's two-step procedure,7 notably by addition of
sodium chloride to facilitate water removal and extraction aer
evaporation, we were able to obtain 4 from 3 in near 80% yield in
15 gram scale. Bis-TBS protection followed by DIBAL-H reduc-
tion and quenching the reaction at a low temperature (78 C)
provided the protected trans-dihydroxylactol 2a in nearly 70%
overall yield and >10 gram scale from 3 (Scheme 2).
We next investigated the practical synthesis of 2b which is
the enantiomer of 2a using D-tartaric acid 6a as the starting
material (Scheme 3). Esterication followed by benzyl protec-
tion of 6a afforded 8a in excellent yield. Reduction of 8a with
KBH4/LiCl led to 1,4-diol 9a in 85% yield. Selective oxidation of
9a by 2-iodoxybenzoic acid (IBX) in DMSO produced the desired
lactol 2b in 87% yield. The lactol 2c, which is the benzyl pro-
tected equivalent of 2a, was obtained in 64% overall yield in the
same sequence from L-tartaric acid 6b. These short routes
provide convenient and practical access to both TBS and benzyl
protected trans-dihydroxybutyrolactols (2a–c) in multigram
scales for synthetic applications.
Although the reaction of protected cis-dihydroxybutyrolactol
with Grignard reagents at low temperature is well known to form
anti product with high diastereoselectivity,8 the reaction ofScheme 2 Reagents and conditions: (a) (i) Na2CO3, H2O2, 5–15 C then charcoal,
75 C; (ii) 6 M HCl, pH 1.5, evap. to dry, extract with EtOAc at reflux, 79%; (b)
TBSCl, imidazoles, DMF, 0 C–rt, 93%; (c) DIBAL-H, THF, 78 C, 1 h then meth-
anol, 1.0 M HCl pH 3, 94%.
This journal is ª The Royal Society of Chemistry 2013protected trans-dihydroxybutyrolactols is much less studied.4a,9
With the protected trans-dihydroxylactols (2a–c) in hand, we set
out to investigate their reaction with various Grignard reagents
(Table 1). The reaction with various organomagnesium reagents
under different conditions (Table 1, entry 1–6) afforded the
addition products in excellent yields and in modest syn selec-
tivity (ca. 3.6 : 1) as determined by 1H NMR analysis of the
product. This level of selectivity is consistent with those reported
in the literature4a,9 and appeared to be not sensitive to temper-
ature as reactions carried out at both 78 C and 0 C gave very
similar selectivities (Table 1, entry 3, 4). The stereochemistry of
the products was conrmed by 1H NMR spectroscopic correla-
tion of lactones II and III to known close analogues IV and V (ref.
10) (Scheme 4). Thus, consecutive oxidation with IBX and Dess–
Martin periodinane (DMP) of diastereomeric mixture 10a
(syn : anti¼ 3.6 : 1) led to the corresponding lactones (II and III).
1H NMR spectra analyses revealed that the lactone II derived
from themajor syn-diastereomer has a smallerH-4,H-5 coupling
constant of 4.8 Hz in agreement with the known IV whereas III
derived from the anti-isomer has a larger coupling constant of
6.6 Hz similar to V. The syn stereochemistry of the major dia-
stereomer was further conrmed in the synthesis of (+)-lentigi-
nosine (Scheme 5, vide infra).
In sharp contrast, the reaction of Grignard reagents with the
corresponding N,O-acetals (VI and VII) formed in situ afforded
predominantly (>99 : 1) the synaminoalcohols (Table1, entry6, 7).
The high syn selectivity is attributed to the good coordinate prob-
ability of imine to form a strong Cram chelation control model.11
Despite modest syn-selectivity in the Grignard addition
reaction, in view of the convenient and scalable access to the
chiral lactol building blocks and high yielding of the reaction,
we sought to explore their application in the synthesis of natural
products. (+)-Lentiginosine, an indolizidine alkaloid with
potent and selective amyloglucosidase inhibition activity,12,13
was selected as an appropriate target for synthetic studies. As
depicted in Scheme 5, permesylation of the diastereomeric 1,4-
diol mixture 10b (syn : anti¼ 3.6 : 1) obtained from the addition
of BnO(CH2)4MgBr to 2a (Table 1, entry 2) led to theRSC Adv., 2013, 3, 20298–20307 | 20299
Table 1 Addition reactions to trans-dihydroxylactols
Entry Substrate RMgX and conditions Product Yielda (%) Syn : antib
1 2a CH2]CHCH2MgBr Et2O/78 C 96 3.6 : 1
2 2a BnO(CH2)4MgBr THF/0 C 93 3.6 : 1
3 2b CH2]CHMgCl THF/78 C 96 3.8 : 1
4 2b CH2]CHMgCl THF/0 C 91 3.6 : 1
5 2c CH2]CHMgCl THF/0 C 92 3.7 : 1
6 2b (i) Benzylamine, 4 Å MS; (ii) CH2]CHMgCl THF/0 C–rt 80 >99 : 1
7 2c (i) Benzylamine, 4 Å MS; (ii) p-CH3O–C6H4CH2MgCl THF/0 C–rt 83 >99 : 1
a Isolated yields. b Determined by 1H NMR spectroscopic analysis.
Scheme 4 Stereochemistry confirmation of the Grignard addition products. (a)
IBX, DMSO, rt, 5 h; 80%; (b) DMP, CH2Cl2, rt, 4 h, 62% for II and 17% for III.













































View Article Onlinecorresponding bismesylate 11. Treatment of 11 with freshly
distilled benzylamine led to the formation of diastereomeric
pyrrolidines 12a and 12b via an efficient one-pot displacement–
cyclization sequence. The diastereomeric mixture was fortu-
nately separable by column chromatography, providing pure
12a and 12b in 18% and 64% yields respectively. However,
removal of the benzyl groups of 12b proved to be quite difficult.
Aer examining various conditions, we nally found that under
hydrogenolysis conditions [Pd(OH)2/C and Pd/C successively,
H2, 1 atm] over four days, alcohol 13 was obtained in 65% yield.
Further intramolecular cyclization of 13 via a one-pot Appel
reaction-cyclization14 led to TBS-protected (+)-lentiginosine 14
in 88% yield. Final TBS deprotection of 14 using TBAF furnished
an efficient total synthesis of (+)-lentiginosine (15) in 5 steps
and 25% overall yield from TBS protected trans-dihydroxylactol
2a. Comparison of the optical rotation of 15 with the reported
value (see Experimental section) conrmed the stereochemistry.This journal is ª The Royal Society of Chemistry 2013
Scheme 5 Total synthesis of (+)-lentiginosine. (a) MsCl, pyridine, 0 C, 12 h, 80%;
(b) BnNH2, 80 C, 48 h, 18% for 12a, 64% for 12b; (c) Pd(OH)2/C, H2, 2 days then














































View Article OnlineHaving demonstrated the usefulness of the Grignard addi-
tion product in alkaloid synthesis, we further explored the
synthetic applications of the amino alcohols, such as 10e/10f,
resulting from the reaction of N,O-acetals (VI and VII) with the
Grignard reagents. These would be more advantageous for
alkaloid synthesis as an amine moiety has already been
installed with much higher stereoselectivity, which would avoid
separating the undesired isomer. Envisioning that the amino
alcohols 10e/10f are the acyclic precursors of pyrrolidine alka-
loids, we anticipated that molecules such as anisomycin (Fig. 1)
could be accessed by concise synthetic sequences (Scheme 6).
()-Anisomycin is a pyrrolidine antibiotic isolated from the
fermentation broths of Streptomyces griseolus. It exhibits strong
and selective activity against pathogenic protozoa and fungi,
and has been used clinically for the treatment of Trichomonas
vaginitis and amoebic dysentery.15 In addition, ()-anisomycin
has been shown to exhibit antiviral and antitumor activities.16
Furthermore, both anisomycin and deacetylanisomycin have
been employed as fungicides in the eradication of bean mildew
and to inhibit other pathogenic fungi in plants.17 Taking
advantage of the highly stereoselective reaction of the N,O-
acetal (VII) with 4-methoxybenzyl magnesium bromide, we
envisioned that amino alcohol (10f) would provide an efficient
synthesis of ()-deacetylanisomycin18 and a formal synthesis ofScheme 6 Formal synthesis of ()-anisomycin. (a) PPh3, CCl4, CH2Cl2, Et3N, 0 C–
rt, 12 h, 90%; (b) Pd(OH)2/C, H2, 3 days, 76%.
This journal is ª The Royal Society of Chemistry 2013()-anisomycin. Thus Appel reaction and in situ cyclization of
10f led to perbenzylated pyrrolidine 16 in 90% yield. Global
debenzylation by hydrogenolysis provided ()-deacetylaniso-
mycin (17) in 76% yield. Since it is well documented that
()-anisomycin can be easily obtained from ()-deacetylaniso-
mycin,4a our synthetic route constitutes one of the most concise
total syntheses of ()-deacetylanisomycin and formal synthesis
of ()-anisomycin.
Conclusion
In conclusion, we have developed two facile synthetic routes to
trans-dihydroxybutyrolactols from inexpensive and abundant
natural chiral starting materials. The overall high yield and
simple chemical transformations enabled their large-scale
syntheses, highlighting the potential industrial applications of
these methodologies. Grignard reactions with these chiral lac-
tols or their aza-analogues provided polyhydroxylated
compounds or amino alcohols. The potential application of the
Grignard addition products were successfully demonstrated in




Optical rotations were recorded on a Perkin-Elmer 341 auto-
matic polarimeter. 1H NMR and 13C NMR spectra were recorded
on Bruker AV400 spectrometer. Unless otherwise indicated, 1H
NMR spectra were obtained in CDCl3, and chemical shis are
expressed in parts per million (ppm) relative to internal Me4Si
standard. IR spectra were recorded on a Nicolet Avatar 360 FT-IR
spectrophotometer using lm or KBr pellet techniques. Mass
spectra were recorded on Bruker Dalton Esquire 3000 plus LC-
MS apparatus. HRMS spectra were recorded on a Bruker APEX-
FTMS apparatus. Melting points were determined by a Yanaco
MP-500 melting point apparatus and are uncorrected. Anhy-
drous solvents were obtained according to procedures provided
in the literature.19 Flash column chromatography was per-
formed on silica gel (300–400 mesh, Zhifu Co Ltd, China)
eluting with ethyl acetate (EtOAc) in petroleum ether (PE, 60–
90 C) mixture unless otherwise noted.
L-Threonic acid-4-lactone (4)
To a stirred cooled (5 C) solution of L-ascorbic acid (28.2 g, 0.16
mol) in water (300 mL) was added Na2CO3 (33.9 g, 0.32 mol) in
portions. Aer 30 min, hydrogen peroxide (30% w/w, 35.2 mL)
was added at a rate that maintained the reaction temperature at
<15 C. The resultingmixturewaswarmed to 40 Candstirred for
30minbefore portionwise addition of charcoal (Norite SG, 4.0 g).
The temperature of themixture was gradually raised to 75 Cand
stirred until hydrogen peroxide had completely decomposed
(negative as tested by starch potassium iodide paper). The
mixture was allowed to cool to room temperature and ltered.
The ltrate was acidied to pH 1.5 with 6.0 M HCl aqueous
solution. Sodium chloride (70 g) was then added and the water













































View Article Onlineextracted with ethyl acetate (500mL) by heating under reux and
ltered hot through Celite. The lter cake was washed with hot
ethyl acetate (3  100 mL). The combined ltrates were evapo-
rated under reduced pressure to give 4 (15.0 g, 79%) as a white
solid. Mp 62–64 C (ref. 20), 61–76 C; [a]20D +28.3 (c 1.2, H2O),21
[a]20D +30.0 (c 1.0,H2O); IR (lm, cm
1): 3353, 2916, 1775; 1HNMR
(500 MHz, CD3COCD3): d 3.93 (dd, J¼ 6.5, 8.0 Hz, 1H, H-4), 4.23
(dd, J¼ 5.5, 6.5Hz, 1H,H-2), 4.34–4.42 (m, 2H,H-3,H-4), 4.97 (d, J
¼ 4.0 Hz, 1H, OH), 5.15 (d, J ¼ 5.5 Hz, 1H, OH); 13C NMR (125
MHz, D2O): d 69.7, 72.4, 73.3, 177.6.
(2R,3S)-2,3-Bis(tert-butyldimethylsilyloxy)-g-butyrolactone (5)
To a solution of 4 (5.1 g, 43.6 mmol) in DMF (45 mL) was added
imidazole (13.9 g, 203.0 mmol) and DMAP (265 mg). The
mixture was stirred and cooled to 0 C followed by dropwise
addition of a solution of TBSCl (18.4 g, 122.0 mmol) in DMF (60
mL) in 60 min. The mixture was allowed to warm to rt and
stirred overnight. The resulting mixture was diluted with
CH2Cl2 (100 mL), washed sequentially with water (5  100 mL),
and brine. The organic phase dried over anhydrous Na2SO4.
Evaporation of the solvents under reduced pressure and puri-
cation of the crude product by ash chromatography on silica
gel (PE : EtOAc¼ 20 : 1) afforded 5 (14.2 g, 94%) as a white solid.
Mp 52–53 C; [a]20D +46.9 (c 1.1, CHCl3),22 ent-5 [a]
20
D 51.0 (c 1.0,
CHCl3); IR (lm, cm
1): 1801; 1H NMR (400 MHz, CDCl3): d 0.09
(s, 3H, SiCH3), 0.11 (s, 3H, SiCH3), 0.15 (s, 3H, SiCH3), 0.20 (s,
3H, SiCH3), 0.90 (s, 9H, SiC(CH3)3), 0.93 (s, 9H, SiC(CH3)3), 4.22
(d, J ¼ 6.3 Hz, 1H, H-2), 4.31–4.37 (m, 2H, H-4), 3.87–3.92 (m,
1H, H-3); 13C NMR (100 MHz, CDCl3): d 5.0, –4.8, –4.7, –4.6,
17.9, 18.2, 25.6, 70.1, 74.5, 75.0, 173.9; ESI-HRMS calcd for
C16H38O4NSi2 (M + NH4)
+: 364.2334; found: 364.2337.
(2R,3S)-2,3-Bis(tert-butyldimethylsilyloxy)-g-butyrolactol (2a)
A solution of 5 (11.2 g, 32.4 mmol) in DCM (100 mL) was stirred
rapidly at 78 C while a 1.0 M solution of DIBAL-H in toluene
(35.6 mL, 35.6 mmol) was added dropwise under N2 over a
period of 30 min. The resulting reaction mixture was stirred for
1 h at 78 C before being quenched by dropwise addition of
methanol (10 mL) and further addition of a mixture of ethyl
acetate and water (1 : 1 mixture, 120 mL). To the resulting
mixture was then added 2 M aqueous sulfuric acid until pH 3.
The mixture was transferred into a separatory funnel where
upon the layers were separated and the aqueous phase was
extracted with ethyl acetate. The combined organic phases were
washed with saturated aqueous sodium bicarbonate solution,
then dried and evaporated under reduced pressure. The crude
product was puried by ash chromatography on silica gel with
PE : EtOAc (20 : 1) to afford 2a (11.1 g, 94%) as a colorless oil.
[a]20D +2.0 (c 0.5, CHCl3); IR (lm, cm
1): 3510, 2955; 1H NMR
(400 MHz, CDCl3) (diastereomixture 1.7 : 1, data of major
isomer): d 0.03–0.15 (m, 12H, SiCH3), 0.89–0.93 (m, 18H,
SiC(CH3)3), 3.68 (d, J ¼ 12.2 Hz, 1H, OH), 3.99–4.05 (m, 3H, H-3,
H-4), 4.08–4.13 (m, 1H, H-2), 5.04 (d, J ¼ 12.2 Hz, 1H, H-1); 13C
NMR (100 MHz, CDCl3): d 5.0, 4.7, 4.6, 17.9, 18.2, 25.7,
74.9, 77.2, 80.3, 103.7; ESI-HRMS calcd for C16H36O4Si2Na (M +
Na)+: 371.2044; found: 371.2046.20302 | RSC Adv., 2013, 3, 20298–20307(2S,3S)-Diethyl 2,3-bis(benzyloxy)succinate (8a)
To a suspension of L-tartaric acid diethyl ester (16.4 g, 79.6
mmol) and silver oxide (74.0 g, 319.0 mmol) in anhydrous
acetonitrile (160 mL) was added dropwise benzyl bromide (28.5
mL, 480 mmol) under mechanically stirring. Aer completion
of the addition, the reaction mixture was stirred at room
temperature for 2 days avoiding light. The mixture was ltered
and the ltrate was concentrated under reduced pressure. The
residue was puried by column chromatography on silica gel
with PE : EtOAc (20 : 1) to give 8a (27.2 g, 88%) as a light yellow
oil. [a]20D 101.1 (c 0.8, CHCl3); IR (lm, cm1): 2988, 1762, 1731,
1443; 1H NMR (400 MHz, CDCl3): d 1.21 (t, J ¼ 7.2 Hz, 6H, CH3),
4.06–4.14 (m, 2H, MeCH2), 4.19–4.27 (m, 2H, MeCH2), 4.42 (s,
2H, CHOBn), 4.48 (d, J ¼ 12.0 Hz, 2H, PhCH2), 4.90 (d, J ¼ 12.0
Hz, 2H, PhCH2), 7.28–7.36 (m, 10H, Ar-H);
13C NMR (100 MHz,
CDCl3): d 4.1, 61.3, 73.2, 78.4, 127.9, 128.3, 128.4, 137.0, 169.2.(2R,3R)-Diethyl 2,3-bis(benzyloxy)succinate (8b)
Following the procedures for the preparation of 8a, 8b was
obtained in 87% yield as a white solid. Mp 46–47 C; [a]20D +107.9
(c 1.0, CHCl3),23 [a]
20
D +105.0 (c 1.0, CHCl3); IR (lm, cm
1): 2988,
1762, 1731, 1443, 1276, 1205, 742, 692; 1H NMR (400 MHz,
CDCl3): d 1.21 (t, J ¼ 7.2 Hz, 6H, CH3), 4.07–4.12 (m, 2H,
MeCH2), 4.21–4.25 (m, 2H, MeCH2), 4.42 (s, 2H, CHOBn), 4.48
(d, J ¼ 12.0 Hz, 2H, PhCH2), 4.90 (d, J ¼ 12.0 Hz, 2H, PhCH2),
7.30–7.34 (m, 10H, Ar-H); 13C NMR (100 MHz, CDCl3): d 14.1,
61.3, 73.2, 78.4, 128.0, 128.3, 128.4, 137.0, 169.2.(2R,3R)-2,3-Bis(benzyloxy)butane-1,4-diol (9a)
To a solution of anhydrous lithium chloride (6.4 g, 150mmol) in
THF (90 mL) was added potassium borohydride (8.2 g, 150
mmol) in one portion and the reaction mixture was stirred at rt
for 4 h under nitrogen. To this solution was added a solution of
8a (23.2 g, 60 mmol) in THF (30 mL) and the resulting mixture
was stirred under reux for 2 h. The reaction was quenched by
the addition of 10% citric acid at 0 C, followed by addition of 2
M aqueous NaOH until the solution was clear. The mixture was
concentrated under vacuum and the aqueous layer was extrac-
ted with ethyl acetate. The combined organic layers were
washed with brine, dried over Na2SO4 and concentrated under
reduced pressure. The residue was puried by column chro-
matography on silica gel with PE : EtOAc (3 : 2) to provide 9a
(15.9 g, 87%) as a colorless oil. [a]20D 10.1 (c 0.78, CHCl3); IR
(lm, cm1): 3435, 2927, 2874, 1450, 1337, 1104; 1H NMR (400
MHz, CDCl3): d 2.34 (br, 2H, OH), 3.68–3.74 (m, 4H, CH2O),
3.82–3.84 (m, 4H, CHO), 4.65 (s, 4H, PhCH2), 7.29–7.38 (m, 10H,
Ar-H); 13C NMR (100 MHz, CDCl3): d 60.8, 72.6, 78.9, 127.9,
128.0, 128.6, 138.0.(2S,3S)-2,3-Bis(benzyloxy)butane-1,4-diol (9b)
Following the above procedures for the preparation of 9a, 9b
was obtained in 87% yield as a colorless oil. [a]20D +10.8 (c 1.0,
CHCl3); IR (lm, cm
1): 3435, 2927, 2874, 1450, 1337, 1104; 1H
NMR (400 MHz, CDCl3): d 2.33 (br, 2H, OH), 3.70–3.74 (m, 4H,













































View Article Online(m, 10H, Ar-H); 13C NMR (100 MHz, CDCl3): d 60.8, 72.6, 78.9,
127.9, 128.0, 128.6, 138.0.
(3S,4R)-3,4-Bis(benzyloxy)tetrahydrofuran-2-ol (2b)
To a solution of 9a (12.4 g, 41.2 mmol) in acetone (80 mL) was
added a solution of IBX (13.6 g, 16.4 mmol) in DMSO (50 mL).
Aer stirred at rt for 5 h, the reaction mixture was quenched by
the addition of water (40 mL), then ltered and the ltrate was
concentrated under reduced pressure. The residue was parti-
tioned between water and CH2Cl2 and the aqueous layer was
extracted with CH2Cl2. The combined organic layers were
washed with brine, dried over Na2SO4 and concentrated under
reduced pressure. The residue was puried by column chro-
matography on silica gel with PE : EtOAc (2 : 1) to give 2b (10.8
g, 87%) as a colorless oil. [a]20D 12.5 (c 1.2, CHCl3); IR (lm,
cm1): 3448, 1610, 1455; 1H NMR (400 MHz, CD3COCD3) (dia-
stereomixture 1.8 : 1, data of major isomer): d 3.93 (dd, J ¼ 8.9,
5.1 Hz, 1H, H-4), 3.98–4.00 (m, 1H, H-2), 4.06–4.14 (m, 2H, H-3,
H-4), 4.52–4.73 (m, 4H, PhCH2), 5.07 (d, J ¼ 6.6 Hz, 1H, OH),
5.29 (d, J ¼ 6.6 Hz, 1H, H-1), 7.28–7.43 (m, 10H, Ar-H); 13C NMR
(100 MHz, CDCl3): d 69.2, 71.9, 73.0, 81.0, 84.9, 101.0, 127.7,
127.9, 128.0, 128.2, 128.5, 128.6, 136.8, 137.4; ESI-HRMS calcd
for C18H20O4Na (M + Na)
+: 323.1254; found: 323.1249.
(3R,4S)-3,4-Bis(benzyloxy)tetrahydrofuran-2-ol (2c)
Following the above procedures for the preparation of 2b, 2c
was obtained in 87% yield as a colorless oil. [a]20D +13.5 (c 1.3,
CHCl3); IR (lm, cm
1): 3443, 1606, 1450; 1H NMR (400 MHz,
CD3COCD3) (diastereomixture 1.8 : 1, data of major isomer): d
3.93 (dd, J ¼ 8.9, 5.1 Hz, 1H, H-4), 3.97–4.00 (m, 1H, H-2), 4.06–
4.14 (m, 2H, H-3, H-4), 4.54–4.70 (m, 4H, PhCH2), 5.06 (d, J¼ 5.8
Hz, 1H, OH), 5.29 (dd, J ¼ 5.8, 1.1 Hz, 1H, H-1), 7.28–7.43 (m,
10H, Ar-H); 13C NMR (100 MHz, CDCl3): d 69.2, 71.9, 73.0, 81.0,
82.2, 101.0, 127.7, 127.9, 128.0, 128.2, 128.5, 128.6, 136.8, 137.4;





To a suspension of magnesium turnings (2.2 g, 91.2 mmol) and
several crystals of iodine in dry Et2O (5 mL) wad added a few
drops of allyl bromide under nitrogen. Aer the reaction had
initiated, the mixture was cooled to 0 C and a solution of allyl
bromide (1.4 mL, 16.0 mmol) in Et2O (48 mL) was added slowly
during 30 min under vigorously stirring. The resulting mixture
was allowed to warm to rt and stirred for 1 h followed by cooling
to 78 C. A solution of 2a (1.1 g, 3.2 mmol) in Et2O (4 mL) was
added dropwise and stirred for 1 h followed by being warmed to
rt and stirred overnight. The reaction was quenched with sat.
aq. NH4Cl, extracted with Et2O (3  10 mL). The combined
organic phases were dried and evaporated under reduced
pressure. The residue was puried by ash chromatography on
silica gel with PE : EtOAc (10 : 1) to afford 10a (1.2 g, 96%) as a
colorless oil. [a]20D 14.6 (c 0.85, CHCl3); IR (lm cm1): 3434,
3000; 1H NMR (400 MHz, CD3COCD3) (diastereomixture): d
0.11–0.16 (m, 12H, Si(CH3)2), 0.86–0.95 (m, 18H, SiC(CH3)3),This journal is ª The Royal Society of Chemistry 20132.10–2.46 (m, 2H, H-5), 2.8 (s, 2H, OH), 3.63–3.96 (m, 5H, H-1,
H-2, H-3, H-4), 4.97–5.07 (m, 2H, H-7), 5.91–5.98 (m, 1H, H-6);
13C NMR (100 MHz, CD3COCD3): d 5.7, 5.3, 5.2, 5.1, 17.6,
25.1, 25.2, 38.3, 61.8, 72.1, 74.8, 76.4, 115.3, 136.0; ESI-HRMS
calcd for C19H42O4Si2Na (M + Na)
+: 413.2514; found: 413.2518.
(2R,3R)-2,3-Bis(benzyloxy)hex-5-ene-1,4-diol (10c)
To a solution of 2b (0.9 g, 3.0 mmol) in dry THF (6 mL) was
added dropwise a solution of vinylmagnesium chloride in THF
(15% wt, 4.4 mL, 7.5 mmol) at 0 C under nitrogen. Aer addi-
tion was complete, the reaction mixture was allowed to stir at rt
for 2 h. The reaction mixture was then quenched with saturated
aqueous NH4Cl and ltered. The ltrate was concentrated under
reduced pressure and extracted with ethyl acetate (30 mL). The
combined organic solvents were washed with brine, dried over
Na2SO4 and concentrated under reduced pressure. The residue
was puried by column chromatography on silica gel with
PE : EtOAc (7 : 3) to give 10c (0.92 g, 91%) as a colorless oil.
[a]20D 18.5 (c 1.3, CHCl3); IR (lm, cm1): 3402, 3030, 1454; 1H
NMR (400MHz, CDCl3) (diastereomixture 3.6 : 1): d 2.64 (br, 2H,
OH), 3.59 (dd, J ¼ 2.5, 5.7 Hz, 1H, H-3), 3.64–3.67 (m, 1H, H-2),
3.72–3.86 (m, 2H, H-1), 4.35–4.43 (m, 1H, H-4), 4.58–4.75 (m,
4H, PhCH2), 5.17–5.26 (m, 1H, H-6), 5.32–5.42 (m, 1H, H-6),
5.87–5.98 (m, 1H, H-5), 7.28–7.36 (m, 10H, Ar-H); 13C NMR (100
MHz, CDCl3): d 60.6, 61.4, 71.1, 72.2, 72.5, 72.6, 73.1, 74.5, 79.0,
79.3, 80.7, 80.8, 115.7, 116.5, 127.9, 128.0, 128.1, 128.2, 128.5,
137.4, 137.6, 137.7, 138.8, 138.1, 138.5; ESI-HRMS calcd for
C20H24O4Na (M + Na)
+: 351.1567; found: 351.1568.
(2S,3S)-2,3-Bis(benzyloxy)hex-5-ene-1,4-diol (10d)
Following the above procedures to prepare of 10c, 10d were
obtained in 92% yield as a colorless oil. [a]20D +17.8 (c 1.1, CHCl3);
IR (lm, cm1): 3406, 3030, 1601, 1453; 1H NMR (400 MHz,
CDCl3) (diastereomixture 3.7 : 1): d 2.62 (br, 2H, OH), 3.56–3.61
(m, 1H, H-3), 3.62–3.68 (m, 1H, H-2), 3.72–3.86 (m, 2H, H-1),
4.35–4.44 (m, 1H, H-4), 4.58–4.75 (m, 4H, 2  PhCH2), 5.16–5.27
(m, 1H, H-6), 5.31–5.42 (m, 1H, H-6), 5.87–5.98 (m, 1H, H-5),
7.25–7.36 (m, 10H, Ar-H); 13C NMR (100 MHz, CDCl3): d 60.6,
61.4, 71.1, 72.2, 72.5, 72.6, 73.1, 74.5, 79.0, 80.7, 80.8, 115.7,
116.5, 127.9, 128.0, 128.2, 128.5, 128.6, 137.4, 137.8, 138.8.
(2S,3S)-8-(Benzyloxy)-2,3-bis(tert-butyldimethylsilyloxy)
octane-1,4-diol (10b)
To a suspension of magnesium turnings (360.0 mg, 15.0 mmol)
and several crystals of iodine in THF (2mL) wad added dropwise
a solution of (4-benzyloxy)butyl bromide (2.4 g, 10.0 mmol) in
THF (10 mL). Aer addition was completed, the resulting
mixture was heated to reux for 30 min, then cooled to 0 C and
a solution of 2a (0.69 g, 2.0 mmol) in THF (5 mL) was added
dropwise. Aer addition was completed, the resulting mixture
was stirred for 2 h at rt, quenched with sat. aq. NH4Cl, extracted
with Et2O (3 10mL). The combined organic phases were dried
and evaporated under reduced pressure, and the residue was
puried by ash chromatography on silica gel with PE : EtOAc
(10 : 1) to give 10b (0.95 g, 93%) as a colorless oil. [a]20D 17.3 (c
0.70, CH2Cl2); IR (lm, cm













































View Article OnlineCDCl3): d 0.06–0.15 (m, 12H, Si(CH3)2), 0.88–0.92 (m, 18H,
SiC(CH3)3), 1.38–1.70 (m, 6H, H-5, H-6, H-7), 2.57 (br, 1H, OH),
2.98 (br, 1H, OH), 3.48 (t, J¼ 6.8 Hz, 2H, H-8), 3.51–3.54 (m, 1H,
H-3), 3.59–3.77 (m, 4H, H-1, H-2, H-4), 4.50 (s, 2H, PhCH2), 7.27–
7.34 (m, 5H, Ar-H); 13C NMR (100 MHz, CDCl3): d 4.3, 4.2,
17.6, 17.9, 18.0, 22.1, 22.8, 25.7, 25.8, 29.7, 29.9, 34.0, 35.5, 61.8,
62.7, 67.6, 70.3, 70.5, 72.9, 73.0, 73.8, 75.0, 75.3, 76.0, 77.2,
127.5, 127.6, 128.3, 138.6; ESI-HRMS calcd for C27H2O5Si2Na (M
+ Na)+: 535.3245; found: 535.3245.
(2R,3R,4S)-4-(Benzylamino)-2,3-bis(benzyloxy)hex-5-en-1-ol (10e)
To a solution of 2b (2.25 g, 7.5 mmol) in dry CH2Cl2 (20 mL) was
added pulverized 4 Å molecular sieves (3 g), followed by ben-
zylamine (0.99 mL, 9.0 mmol). The resulting mixture was stirred
at rt under N2 for 4 h. Themolecular sieves was then removed by
ltration and washed with dry CH2Cl2. The combined ltrates
were evaporated under reduced pressure to provide a pale
yellow oil (2.9 g) which was dissolved in dry THF (7.5 mL) and
cooled to 0 C. To the solution was added a solution of vinyl-
magnesium chloride in THF (15% wt, 17.8 mL, 30.0 mmol). The
resulting reaction mixture was warmed to rt and stirred for 3 h,
quenched with saturated aqueous NH4Cl. The solid was
removed by ltration and the ltrate was extracted with diethyl
ether (3  10 mL). The combined organic extracts were washed
with brine, dried and evaporated under reduced pressure. The
residue was puried by ash chromatography on silica gel with
PE : EtOA (7 : 3) to afford 10e (2.5 g, 80%) as a colorless oil.
[a]20D 15.9 (c 1.05, CHCl3); IR (lm, cm1): 3316, 3063, 1496,
1453; 1H NMR (400 MHz, CD3COCD3): d 2.8 (br, 2H, OH, NHBn),
3.41 (dd, J ¼ 3.0, 8.6 Hz, 1H, H-4), 3.55 (d, J ¼ 13.0 Hz, 1H,
PhCH2N), 3.68–3.82 (m, 4H, H-1, H-2, H-3), 3.84 (d, J ¼ 13.0 Hz,
1H, PhCH2N), 4.57 (d, J¼ 11.7 Hz, 1H, PhCH2O), 4.59 (d, J¼ 11.7
Hz, 1H, PhCH2O), 4.75 (d, J ¼ 11.3 Hz, 2H, PhCH2O), 5.15–5.26
(m, 2H, CH]CH2), 5.94 (ddd, J ¼ 8.6, 10.3, 17.2 Hz, 1H, CH]
CH2), 7.22–7.36 (m, 15H, Ar-H);
13C NMR (100 MHz, CDCl3): d
50.9, 57.9, 58.8, 71.1, 73.9, 82.5, 117.8, 127.3, 127.7, 127.9, 128.0,
128.4, 128.6, 128.8, 137.9, 138.2, 138.4, 138.8; ESI-HRMS calcd
for C22H29O8S2 (M + H)
+: 418.2377; found: 418.2381.
(2S,3S,4R)-4-(Benzylamino)-2,3-bis(benzyloxy)-5-(4-methoxy-
phenyl)pentan-1-ol (10f)
To a solution of 2c (1.2 g, 4.0 mmol) in dry CH2Cl2 (20 mL) was
added pulverized 4 Å molecular sieves (1.6 g) followed by ben-
zylamine (0.53 mL, 4.8 mmol). The resulting mixture was stirred
for 4 h at rt under nitrogen. The solid was then removed by
ltration and washed with dry CH2Cl2. The combined organic
ltrates were concentrated under reduced pressure to provide
the corresponding crudeN,O-acetal (VII) a pale yellowoil (1.56 g).
To a suspension of magnesium turnings (1.2 g, 48.0 mmol)
and iodine (50mg) in THF (5mL) wad added dropwise a solution
of 4-methoxybenzyl chloride (5.4mL, 40.0mmol) inTHF (40mL).
The resultingmixture was heated to reux for 30min to afford 4-
methoxybenzylmagnesium chloride whichwas then cooledwith
an ice bath and added a solution of the above N,O-acetal in dry
THF (4 mL). The mixture was stirred for 3 h then quenched with
sat. aq. NH4Cl, extracted with ether (3  8 mL). The combined20304 | RSC Adv., 2013, 3, 20298–20307organic layers were washed with brine, dried over Na2SO4. The
solvent was removed under reduced pressure and the residue
was puried by ash chromatography on silica gel with
PE : EtOAc (2 : 1) to give 10f as a colorless oil (1.7 g, 83%).
[a]20D 25.9 (c 0.56, CHCl3); IR (lm, cm1): 3332, 3060, 1610,
1511, 1454; 1H NMR (400 MHz, CD3COCD3): d 2.70 (d, J ¼ 13.0,
8.9 Hz, 1H, H-5), 2.82 (br, 2H, OH,NHBn), 3.13–3.24 (m, 2H, H-4,
H-5), 3.65–3.71 (m, 3H, H-1, H-2, H-3), 3.74–3.81 (m, 5H, CH3O,
H-1, PhCH2N), 4.02 (d, J¼ 12.5 Hz, PhCH2N), 4.38 (d, J¼ 12.0 Hz,
PhCH2O), 4.51 (d, J ¼ 11.6 Hz, PhCH2O), 4.57 (d, J ¼ 12.0 Hz,
PhCH2O), 4.73 (d, J ¼ 11.6 Hz, PhCH2O), 6.83 (d, J ¼ 8.7 Hz, 2H,
Ar-H), 7.02 (d, J¼ 8.7Hz, 2H, Ar-H), 7.14–7.38 (m, 15H, Ar-H); 13C
NMR (100 MHz, CDCl3): d 35.2, 50.9, 55.3, 56.9, 58.9, 71.2, 72.8,
76.7, 77.9, 114.1, 127.5, 127.7, 128.0, 128.2, 128.3, 128.6, 128.7,
128.8, 130.2, 131.2, 138.2, 138.4, 138.7, 159.2; ESI-HRMS calcd
for C20H44NO2Si2 (M + H)
+:512.2795; found: 512.2800.(3R,4S,5R)-5-Allyl-3,4-bis(tert-butyldimethylsilyloxy)-
dihydrofuran-2(3H)-one (II) and (3R,4S,5S)-5-allyl-3,4-
bis(tert-butyldimethylsilyloxy)dihydrofuran-2(3H)-one (III)
To a solution of 10a (165.0 mg, 0.42 mmol) in acetone (1 mL)
was added a solution of IBX (142.1 mg, 0.51 mmol) in DMSO
(0.4 mL). Aer stirred at rt for 5 h, the reaction mixture was
quenched by the addition of water (10 mL), then ltered and the
ltrate was concentrated under reduced pressure. The residue
was partitioned between water and CH2Cl2 and the aqueous
layer was extracted with CH2Cl2. The combined organic layers
were washed with brine, dried over Na2SO4 and concentrated
under reduced pressure to give a crude colorless oil.
To a solution of above oil in CH2Cl2 (0.5 mL) was added a
solution of DMP (216.0 mg, 0.51 mmol) in CH2Cl2 (2 mL) at rt,
the result reaction mixture was stirred for 4 h, then diluted with
water (2 mL), extracted with CH2Cl2 (3  5 mL), The combined
organic layers were washed with brine, dried over Na2SO4 and
concentrated under reduced pressure, puried by column
chromatography on silica gel with PE : EtOAc (10 : 1) to give II
(81.2 mg, 62%) and III (22.7 mg, 17%).
II: [a]20D +60.5 (c 0.77, CHCl3); IR (lm, cm
1): 2954, 1793; 1H
NMR (400 MHz, CDCl3): d 0.13 (s, 3H, Si(CH3)2), 0.14 (s, 3H,
Si(CH3)2), 0.17 (s, 3H, Si(CH3)2),0.18 (s, 3H, Si(CH3)2), 0.92 (s, 18H,
2  SiC(CH3)3), 2.47–2.50 (m, 2H, CH2CH]CH2), 4.14 (d, J ¼ 4.4
Hz, 1H,H-3), 4.21 (pseudo-t, J¼ 4.8, 4.6Hz,H-4), 4.56–4.61 (m, 1H,
H-5), 5.15–5.24 (m, 2H, CH]CH2), 5.82–5.93 (m, 1H, CH]CH2);
13C NMR (100 MHz, CDCl3): d 5.1, 4.9, 4.7, 4.6, 17.9, 18.1,
25.6, 25.7, 33.4, 74.7, 75.4, 81.3, 118.5, 133.0, 178.8; ESI-HRMS
calcd for C19H38O4Si2Na (M + Na)
+: 409.2206; found: 409.2210.
III: [a]20D +4.4 (c 0.27, CHCl3); IR (lm, cm
1): 2960, 1795; 1H
NMR (400 MHz, CDCl3): d 0.13 (s, 3H, Si(CH3)2), 0.14 (s, 3H,
Si(CH3)2), 0.19 (s, 3H, Si(CH3)2), 0.21 (s, 3H, Si(CH3)2), 0.85 (s,
9H, SiC(CH3)3), 0.92 (s, 9H, SiC(CH3)3), 2.38–2.42 (m, 1H,
CH2CH]CH2), 2.55–2.53 (m, 1H, CH2CH]CH2), 3.98 (pseudo-t,
J ¼ 6.5 Hz, H-4), 4.10–4.16 (m, 1H, H-5), 4.26 (d, J ¼ 6.6 Hz, 1H,
H-3), 5.15–5.22 (m, 2H, CH]CH2), 5.77–5.88 (m, 1H, CH]CH2);
13C NMR (100 MHz, CDCl3): d4.8,4.5,4.4,4.0, 17.8, 18.2,
25.6, 25.7, 36.1, 76.0, 77.9, 81.5, 118.9, 132.1, 173.4; ESI-HRMS
calcd for C19H38O4Si2Na (M + Na)















































To a stirred solution of 4-(dimethylamino)pyridine (DMAP)
(61.0 mg, 0.05 mmol) andMsCl (0.77 mL, 1.00 mmol) in pyridine
(0.5 mL) cooled to 0 C was added dropwise a solution of 10b
(128.5 mg, 0.25 mmol) in pyridine (0.25 mL). The resulting
reaction mixture was stirred at 0 C for 12 h, then poured into
ice water (5 mL) and extracted with Et2O (3  1 mL). The
combined organic phases were washed with saturated aqueous
CuSO4, dried over Na2SO4. The solvent was evaporated under
reduced pressure and the residue was puried by ash chro-
matography on silica gel by gradient elution with PE : EtOAc
(20 : 1 to 10 : 1) to give 11 (134 mg, 80%) as a colorless oil.
[a]20D 21.4 (c 0.98, CH2Cl2); IR (lm, cm1): 1598, 1458; 1H NMR
(400 MHz, CDCl3) (diastereomixture 3.7 : 1, data of major
isomer): d 0.09 (s, 3H, SiCH3), 0.10 (s, 3H, SiCH3), 0.12 (s, 3H,
SiCH3), 0.14 (s, 3H, SiCH3), 0.91 (s, 9H, SiC(CH3)3), 0.92 (s, 9H,
SiC(CH3)3), 1.40–1.43 (m, 2H, H-6), 1.62–1.67 (m, 2H, H-7), 1.82–
1.97 (m, 2H, H-7), 2.99 (s, 3H, CH3SO2), 3.02 (s, 3H, CH3SO2),
3.47 (t, J¼ 6.3 Hz, 2H, CH2OBn), 3.81 (dd, J¼ 2.3, 5.4 Hz, 1H, H-
3), 4.02–4.07 (m, 1H, H-2), 4.36 (dd, J ¼ 8.1, 10.2 Hz, 1H, H-1),
4.46–4.52 (m, 3H, PhCH2, H-10), 4.91–4.93 (m, 1H, H-4), 7.27–
7.36 (m, 5H, Ar-H); 13C NMR (100 MHz, CDCl3): d 4.9, 4.7,
17.8, 18.0, 22.2, 25.3, 25.6, 25.7, 29.3, 30.7, 36.7, 39.4, 69.6, 70.9,
72.1, 72.8, 79.5, 84.2, 127.4, 127.5, 128.2, 138.4; ESI-HRMS calcd
for C29H60O9NS2Si2 (M + NH4)




To freshlydistilledbenzyl amine (0.5mL)was added11 (146.0mg,
0.22mmol), the resulting reactionmixturewas stirred at 80 C for
2 days, then cooled and diluted with diethyl ether (3 mL). The
solid was removed by ltration, and the ltrate was concentrated
under reduced pressure. The residue was puried by ash chro-
matography on silica gel with PE : EtOAc (10 : 1) to afford 12a
(21.6 mg, 18%) and 12b (77.7 mg, 64%) as colorless oils.
12a: [a]20D 14.9 (c 0.94, CH2Cl2); IR (lm, cm1): 1598, 1466,
1361, 1248; 1H NMR (400 MHz, CDCl3): d 0.08 (s, 3H, SiCH3),
0.09 (s, 3H, SiCH3), 0.11 (s, 3H, SiCH3), 0.12 (s, 3H, SiCH3), 0.90
(s, 9H, SiC(CH3)3), 0.95 (s, 9H, SiC(CH3)3), 1.44–1.71 (m, 6H, H-
6, H-7, H-8), 2.27–2.31 (m, 1H, H-2), 2.83–2.85 (m, 1H, H-5), 3.19
(dd, J ¼ 10.4, 4.3 Hz, 1H, H-5), 3.51 (t, J ¼ 6.7 Hz, 2H, CH2OBn),
3.57 (d, J ¼ 13.4 Hz, 1H, PhCH2N), 3.95–4.01 (m, 3H, H-3, H-4,
PhCH2N), 4.55 (s, 2H, PhCH2O), 7.27–7.38 (m, 10H, Ar-H);
13C
NMR (100 MHz, CDCl3): d 4.7, 4.6, 4.5, 4.2, 17.9, 18.1,
23.5, 25.8, 25.9, 28.6, 30.3, 58.9, 60.4, 66.6, 70.5, 72.8, 77.7, 79.3,
126.6, 127.4, 127.6, 128.1, 128.3, 128.7, 138.7, 140.2; HRMS
calcd for C34H58NO3Si2 (M + H)
+: 584.3950; found: 584.3945.
12b: [a]20D +40.4 (c 0.55, CH2Cl2); IR (lm, cm
1): 1598, 1466,
1361, 1248; 1H NMR (400 MHz, CDCl3): d 0.08 (s, 3H, SiCH3),
0.09 (s, 3H, SiCH3), 0.11 (s, 3H, SiCH3), 0.12 (s, 3H, SiCH3), 0.90
(s, 9H, SiC(CH3)3), 0.95 (s, 9H, SiC(CH3)3), 1.50–1.75 (m, 6H, H-
6, H-7, H-8), 2.49–2.52 (m, 1H, H-2), 2.57 (dd, J ¼ 5.2, 10.3 Hz,
1H, H-5), 2.82 (d, J ¼ 10.3 Hz, 1H, H-5), 3.36 (d, J ¼ 13.6 Hz, 1H,This journal is ª The Royal Society of Chemistry 2013PhCH2N), 3.52 (t, J ¼ 6.6 Hz, 2H, CH2OBn), 3.87 (dd, J ¼ 2.2, 3.6
Hz, 1H, H-3), 3.95–3.96 (m, 1H, H-4), 4.03 (d, J ¼ 13.6 Hz, 1H,
PhCH2N), 4.54 (s, 2H, PhCH2O), 7.28–7.40 (m, 10H, Ar-H);
13C
NMR (100 MHz, CDCl3): d 4.7, 4.6, 4.4, 4.2, 17.9, 18.0,
22.1, 25.8, 30.2, 31.2, 59.1, 59.7, 70.5, 71.3, 72.9, 78.3, 83.1,
126.6, 127.4, 127.6, 128.1, 128.3, 128.5, 138.7, 140.0; HRMS
calcd for C34H58NO3Si2 (M + H)
+: 584.3950; found: 584.3957.
4-[(2S,3S,4S)-3,4-Bis(tert-butyldimethylsilyloxy)pyrrolidin-2-yl]-
butan-1-ol (13)
To a solution of 12b (240.0 mg, 0.41 mmol) in MeOH (5 mL) was
added Pd(OH)2/C (200.0 mg) and the resulting mixture was
stirred under H2 (balloon, 1 atm) for 2 days. The catalyst was
ltered and to the ltrate was added Pd/C (200 mg). The
resulting mixture was stirred for an additional 4 days under H2
(balloon, 1 atm). The solid was ltered and the ltrate was
evaporated under reduced pressure. The residue was puried by
ash chromatography on silica gel with PE : EtOAc (1 : 2) to give
13 (108.0 mg, 65%) as a colorless oil. [a]20D +18.5 (c 1.82, CH2Cl2);
IR (lm, cm1): 3342; 1H NMR (400 MHz, CD3COCD3): d 0.08 (s,
3H, Si(CH3)), 0.09 (s, 3H, Si(CH3)), 0.11 (s, 3H, Si(CH3)), 0.12 (s,
3H, Si(CH3)), 0.90 (s, 9H, SiC(CH3)3), 0.91 (s, 9H, SiC(CH3)3),
1.48–1.58 (m, 6H, H-6, H-7, H-8), 2.06–2.09 (m, 1H, H-2), 2.23
(br, 2H, OH, NH), 2.54 (dd, J ¼ 6.4, 10 Hz, 1H, H-5), 2.87 (dt, J ¼
10, 0.8 Hz, 1H, H-5), 3.54 (t, J ¼ 6.4 Hz, 2H, PhCH2O), 3.83 (dd, J
¼ 2.0, 4.8 Hz, 1H, H-3), 3.97 (dd, J ¼ 2.0, 5.6 Hz, 1H, H-4); 13C
NMR (100 MHz, CDCl3): d 4.7, 4.6, 4.3, 4.2, 17.8, 18.0,
21.7, 25.8, 25.9, 30.7, 33.0, 62.4, 63.1, 73.7, 78.5, 83.6; ESI-HRMS
calcd for C20H46NO3Si2 (M + H)
+: 404.3016; found: 404.3014.
(1S,2S,8aS)-1,2-Bis(tert-butyldimethylsilyloxy)-
octahydroindolizine (14)
To cooled (0 C) solution of 13 (80.4 mg, 0.2 mmol) and PPh3
(104.8 mg, 0.4 mmol) in dry CH2Cl2 (1 mL) was added dropwise
fresh distilled CCl4 (38.8 mL, 0.4 mmol). The resulting mixture
was warmed to rt and stirred for 1 h followed by addition Et3N
(56 mL, 0.4 mmol). The resulting reactionmixture was stirred for
12 h followed by evaporation of the solvent. The crude product
was puried by ash chromatography on silica gel with
PE : EtOAc (10 : 1) to give 14 (77.2 mg, 88%) as colorless oil.
[a]20D +8.9 (c 0.80, CHCl3); IR (lm, cm
1): 2933, 2855; 1H NMR
(400 MHz, CDCl3): d 0.03 (s, 3H, Si(CH3)), 0.05 (s, 3H, Si(CH3)),
0.06 (s, 3H, Si(CH3)), 0.08 (s, 3H, Si(CH3)), 0.87–0.91 (m, 18H,
SiC(CH3)3), 1.16–1.27 (m, 2H, H-6, H-7), 1.53–1.61 (m, 2H, H-6,
H-7), 1.72–1.95 (m, 4H, H-5, H-8, H-8a), 2.52 (dd, J ¼ 7.9, 10.1
Hz, 1H, H-3), 2.84 (dd, J¼ 2.1, 10.1 Hz, 1H, H-3), 2.91 (dt, J¼ 3.2,
10.8 Hz, 1H, H-5), 3.72 (dd, J ¼ 4.1, 8.5 Hz, 1H, H-1), 3.98 (ddd, J
¼ 2.1, 4.1, 7.9 Hz, 1H, H-2); 13C NMR (100 MHz, CDCl3): d 4.7,
4.2, 4.1, 17.9, 18.0, 24.0, 24.9, 25.9, 26.0, 28.7, 53.4, 62.1,




To a solution of 14 (38.6 mg, 0.1 mmol) in dry THF (0.5 mL) was
added TBAF (1 M in THF, 0.4 mL) and the resulting mixture was













































View Article Onlinereduced pressure and the crude product was puried by ash
chromatography on silica gel with CH2Cl2 : MeOH : NH3$H2O
(85 : 15 : 1) to give (+)-lentiginosine as a white solid (14.1 mg,
90%). Mp 105–106 C,24 106–107 C; [a]20D +3.1 (c 0.28, MeOH),24
[a]20D +3.1 (c 0.31, MeOH); IR (KBr, cm
1): 3405; 1H NMR (400
MHz, D2O): d 1.24–1.34 (m, 2H, H-6, H-7), 1.42–1.54 (m, 1H, H-
7), 1.62–1.72 (m, 1H, H-6), 1.78–1.88 (m, 1H, H-8), 1.92–2.04 (m,
2H, H-5, H-8a), 2.10 (td, J ¼ 11.9, 3.0 Hz, 1H, H-8), 2.68 (dd, J ¼
11.3, 7.5 Hz, 1H, H-3), 2.87 (dd, J ¼ 11.3, 1.6 Hz, H-3), 2.98 (br d,
J ¼ 11.1 Hz, H-5), 3.68 (dd, J ¼ 3.9, 8.8 Hz, 1H, H-1), 4.09 (ddd, J
¼ 1.8, 3.9, 7.5 Hz, 1H, H-2); 13C NMR (100 MHz, D2O): d 24.8,
25.8, 29.3, 54.5, 62.0, 70.4, 77.4, 84.7.(2R,3S,4S)-2-(4-Methoxybenzyl)-1-benzyl-3,4-bis(benzyloxy)-
pyrrolidine (16)
To a solution of 10f (1.2 g, 2.3 mmol) and PPh3 (1.2 g, 4.7 mmol)
in DMF (12 mL) was added CCl4 (0.46 mL, 4.7 mmol) dropwise
at 0 C. Aer 30 min, the resulting mixture was warmed to rt,
followed by dropwise addition of Et3N (0.66 mL, 4.7 mmol). The
mixture was stirred overnight, ltered, and the ltrate was
concentrated under reduced pressure. The residue was puried
by ash chromatography on silica gel with PE : EtOAc (1 : 2) to
give 16 (1.0 g, 90%) as a colorless oil. [a]20D 66.7 (c 0.39, CHCl3);
IR (lm, cm1): 1511, 1454; 1H NMR (400 MHz, CDCl3): d 2.29
(dd, J ¼ 5.0, 10.4 Hz, 1H, H-5), 2.83–2.91 (m, 1H, H-5), 2.95–3.05
(m, 1H, (MeO)PhCH2), 3.32–3.38 (m, 2H, H-2, PhCH2N), 3.72 (br
d, J¼ 13.2 Hz, 1H, H-3), 3.78 (s, 3H, CH3O), 3.92–2.98 (m, 1H, H-
4), 4.04 (d, J ¼ 13.0 Hz, 1H, PhCH2N), 4.32–4.42 (m, 3H,
PhCH2O), 4.50 (d, J ¼ 11.8 Hz, 1H, PhCH2O), 6.78 (d, J ¼ 8.5 Hz,
2H, Ar-H), 7.11 (d, J ¼ 8.5 Hz, 2H, Ar-H), 7.21–7.35 (m, 15H, Ar-
H); 13C NMR (100 MHz, CDCl3): d 32.9, 55.3, 58.1, 59.0, 68.4,
71.3, 71.7, 81.2, 83.5, 113.7, 126.9, 127.6, 127.7, 128.0, 128.3,
128.4, 129.1, 130.2, 132.0, 138.1, 138.3, 138.7, 157.8; ESI-HRMS
calcd for C20H42NOSi2 (M + H)
+: 494.2690; found: 494.2698.(2R,3S,4S)-2-(4-Methoxybenzyl)pyrrolidine-3,4-diol
[()-deacetylanisomycin] (17)
To a solution of 16 (493.6 mg, 1.0 mmol) in EtOH (5 mL) was
added Pd(OH)2/C (200.0 mg) and the mixture was stirred under
hydrogen atmosphere (1 atm) at rt for 3 days. The mixture was
ltered and the ltrate concentrated under reduced pressure.
The crude product was puried by ash chromatography on
silica gel with PE : EtOAc (1 : 2) to give ()-deacetylanisomycin
(169.0 mg, 76%) as a white solid. Mp 174–175 C,4a 176–177 C,25
173–174 C; [a]20D 21.0 (c 0.39, MeOH),26 [a]20D 22.5 (c 0.84,
MeOH); 1H NMR (400 MHz, CDCl3): d 2.76–2.83 (m, 2H, (MeO)
PhCH2), 2.98 (dd, J¼ 6.5, 12.9 Hz, 1H, H-5), 3.37 (dd, J¼ 5.4, 12.9
Hz, 1H, H-5), 3.51–3.57 (m, 1H, H-2), 3.82 (s, 3H, CH3O), 3.97–
4.01 (m, 1H, H-3), 4.23–4.28 (m, 1H, H-4), 6.98 (d, J¼ 8.7 Hz, 2H,
Ar-H), 7.29 (d, J¼ 8.7Hz, 2H, Ar-H); 13CNMR (100MHz, CDCl3): d
32.2, 51.0, 55.3, 62.5, 76.2, 76.5, 114.2, 130.1, 131.1, 157.4.Acknowledgements
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